Lv23
148 积分 2022-08-01 加入
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease
2天前
已完结
CAR-T cells generated in vivo for the targeted treatment of myocardial fibrosis
2天前
已完结
Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved Diseases
5天前
已完结
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis
5天前
已完结
CAR T cells produced in vivo to treat cardiac injury
5天前
已完结
From bench to bloodstream: Lipid nanoparticles drive on-demand CAR-T cells
5天前
已完结
In vivo CAR T cells move into clinical trials
5天前
已完结
Abstract 5184: From tLNP selection to in vitro/vivo efficiency evaluation: In vivo CAR-T therapy
5天前
已关闭
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
6天前
已完结
Decreasing colorectal cancer extracellular pH dampens immune cell killing and is partially ameliorated by treatment with NHE1 inhibitor Cariporide
12天前
已关闭
皖公网安备34019202002308
